Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 3/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8663821 | 0.98 | KMT2A (0.48) | KMT2AMEN1MAPTHDAC8TP53 | |
| Hydrochloric Acid SCHEMBL11600265 | 0.98 | MEN1 (0.48) | KMT2AMEN1MAPTHDAC8TP53 | |
| Hydrochloric Acid SCHEMBL8775080 | 0.90 | KMT2A (0.60) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Bromide SCHEMBL5489286 | 0.90 | KMT2A (0.60) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL28333937 | 0.87 | HDAC8 (0.54) | KMT2AMEN1MAPTHDAC8TP53 | |
| SCHEMBL21350643 | 0.87 | HDAC8 (0.52) | KMT2AMEN1MAPTHDAC8TP53 | |
| Bromide SCHEMBL10609243 | 0.85 | HDAC8 (0.52) | KMT2AMEN1MAPTHDAC8TP53 | |
| Bromide SCHEMBL8425884 | 0.85 | HDAC8 (0.50) | HDAC8CYP2A6ACHE | |
| Bromide SCHEMBL8428013 | 0.83 | HDAC8 (0.48) | HDAC8ACHE | |
| Bromide SCHEMBL8425890 | 0.83 | HDAC8 (0.48) | HDAC8ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106661735-B | Palladium plating solution and palladium coating film obtained using the same | 日本高纯度化学株式会社 | 2019-12-10 | — | — | CN | claimed |
| JP-10316661-A | — | — | None | — | — | JP | disclosed |
| US-10626335-B2 | Process for removing metals from hydrocarbons | PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) | 2020-04-21 | — | — | US | disclosed |
| CN-106661735-B | Palladium plating solution and palladium coating film obtained using the same | 日本高纯度化学株式会社 | 2019-12-10 | — | — | CN | disclosed |
| WO-2010116165-A2 | PROCESS FOR REMOVING METALS FROM HYDROCARBONS | PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) | 2010-10-14 | — | — | WO | disclosed |
| JP-H10316661-A | SALT OF 1-(1-BUTYL)-4-CYANOPYRIDINIUM AND ITS PRODUCTION | KOEI CHEM CO LTD | 1998-12-02 | — | — | JP | disclosed |
| US-4182797-A | AS CATHODE WITH LITHIUM ANODE, LITHIUM IODIDE ELECTROLYTE; USED FOR PACRMAKERS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10626335-B2 | Process for removing metals from hydrocarbons | SHH, AHR, HTT | KMT2A 848/4885MEN1 353/4885MAPT 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.